tiprankstipranks

Boston Scientific price target raised to $115 from $100 at Stifel

Stifel analyst Rick Wise raised the firm’s price target on Boston Scientific (BSX) to $115 from $100 and keeps a Buy rating on the shares following what the firm calls “an excellent fourth quarter result.” The company’s positive performance appears primed to continue in 2025, contends the analyst, who expects improvement from Silk Road and Axonics as the company integrates both businesses.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue